Pinned Tweet
היי, אנחנו epm 👋
אל תסתפקו בכותרות באתרים!
אנחנו כאן כדי לדבר איתכם ולספק את כל המידע על ההנפקה הנגישה של החברה שנמצאת בעיצומה בימים אלה.
בואו להכיר אותנו מקרוב:
לעמוד ההנפקה>>https://teapawt.net/t.co/jZIi66mtjH
לקבלת כל המידע באופן אישי>>https://teapawt.net/t.co/HcRBGS0zWY
עקבו אחרינו לעדכונים.
EPM retweeted
Welcome to our delegates as you start to arrive for #IPWSO2022 with @PWSAI! Many thanks to our sponsors for making this event possible. @novonordisk @Radius_Health @fpwr @PWSAUSA @friendsofipwso @Saniona_AB Soleno Therapeutics @OT4Bfrance @epmip Aardvark Therapeutics
קצת על המדע מאחורי החברה:
המחקרים והפיתוח מתבצעים בשיתוף עם אוניברסיטאות וחוקרים בעלי שם עולמי כגון:
פרופ' דן פאר (אוני׳ תל-אביב),
פרופ' יוסף (יוסי) תם (האוני׳ העברית),
פרופ' מרק בראון (מדפארם) ועוד...
עוד על שיתופי הפעולה והמחקרים האקדמיים, פה>>https://teapawt.net/t.co/HFFFiAKIpp
1
הנהלת החברה מתכבדת להכריז כי ההנפקה של EPM נפתחה מחדש בהצעה אחידה להזמנות הציבור.
החברה ביצעה התאמות תוכן באתר Fundit ופרסמה תיקון תשקיף.
לתשקיף החברה>>maya.tase.co.il/reports/deta…
לעמוד ההנפקה>>https://teapawt.net/t.co/jZIi66mtjH
מוזמנים להכנס ולעקוב.
An inspiring interview with Prof. Mechoulam and EPM about a new compound, EPM301, representing the future of cannabinoid acids as new medicine and potential alternative to steroid treatments.
More Potent Than CBD, THC: Dr. Raphael Mechoulam Explains His Latest Discovery
My latest for @Forbes
forbes.com/sites/javierhasse…
EPM retweeted
More Potent Than CBD, THC: Dr. Raphael Mechoulam Explains His Latest Discovery
My latest for @Forbes
forbes.com/sites/javierhasse…
EPM retweeted
Dr. Raphael Mechoulam has discovered a way to create safe and stable synthetic acid forms of THC and CBD, opening the doors for a wide range of new medical treatments. 👨🏻⚕️🧬🔬🧪
https://teapawt.net/t.co/hM3ChmK32b
EPM retweeted
Cannabis research pioneer hopes latest discovery is not overlooked — again ift.tt/2lTlVOB
Great discussion and collaboration at #CannMed2019! Learn more about EPM’s research, how our scientific team was able to industrialize a formula to manufacture stable #cannabinoid acids commercially, and how we are sharing the use of our molecules: epmip.com/#about-us
Prof. Dan Peer explains preclinical data presented at #CannMed2019 that shows promise of #cannabinoid acids in treating #IBD in animal models at @CannMedEvents.
#CannMed2019 | #CannMedinspires | #CannabisScience| #CannabisHealth | #CannabisConference
Prof. Joseph Tam presented data at @CannMedEvents on the potential therapeutic benefits of #cannabinoidacids shown in animal models on diabetes-induced metabolic abnormalities.
#CannMed2019 | #CannMedinspires | #CannabisScience| #CannabisHealth | #CannabisConference
Check out EPM’s CEO Reshef Swisa, speaking to @CannaBusinessMM of @LAWeekly about our mission to bridge the #cannabis and pharmaceutical industries through the company’s new therapeutics development platform. @Benzinga @MediGenomics #CannMedInspires | #CannMed2019
For the first time ever, pharmaceutical companies will have access to a wide variety of patent protected, stable cannabinoid molecules synthesized to provide stability and consistency for use in developing new medicines.
Startup EPM launches, high off acid-based cannabinoid innovation endpts.com/startup-epm-launc…
“We have taken the unstable acid molecules of the cannabis plant and synthesized them to provide a stable, consistent basis for researching new therapies across a wide range of medical needs.” – Prof. Raphael Mechoulam, PhD, head of research, EPM
#CannMedInspires #CannMed2019
#NEWS: Today marks the start of a new era in medical research as EPM introduces an innovative development platform for the use of our fully stable acid-based #cannabinoid molecules at #CannMed2019. Learn more: epmip.com/epm-introduces-gro… #CannMedInspires
4
EPM retweeted
BIG NEWS! Prof. Raphael Mechoulam's keynote at CannMed 2019 will discuss development of new family of stabilized cannabinoid acids. Industry changing. One of last trips to US - are YOU coming to CannMed? Buy NOW!
youtu.be/VKU9Uy5Eafo
@CannMedEvents @MediGenomics @ProjectCBD
Prof. Dan Peer discusses how the company is at the forefront of pioneering #cannabinoid acid research with the potential to impact human health.
#CannMedInspires | #CannabisScience| #CannabisHealth | #CannabisConference | #CannMed2019
The father of #cannabis research and #CannMed2019 keynote speaker, Dr. Raphael Mechoulam, explains EPM’s unprecedented work in #cannabinoid acid molecules.
#CannMedInspires | #CannabisScience| #CannabisHealth | #CannabisConference
EPM was founded to unlock the potential of #cannabinoid acids and bridge the gap between the pharmaceutical and #cannabis industries. Stay tuned for groundbreaking news during #CannMed2019.






















